AquaBounty Technologies, Inc.

NasdaqCM:AQB Stock Report

Market Cap: US$5.3m

AquaBounty Technologies Past Earnings Performance

Past criteria checks 0/6

AquaBounty Technologies has been growing earnings at an average annual rate of 28.5%, while the Biotechs industry saw earnings growing at 36.2% annually. Revenues have been declining at an average rate of 39.4% per year.

Key information

28.47%

Earnings growth rate

33.25%

EPS growth rate

Biotechs Industry Growth17.04%
Revenue growth rate-39.40%
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Mar 2026

Recent past performance updates

Recent updates

Seeking Alpha • Aug 20

AquaBounty: Not Casting A Lure Yet

This land-based salmon producer is a unique take on aquaculture, but risks abound. The current market cap does not take into consideration the low production plans, even with a new facility under construction. The looming clouds on the horizon means I will dock my boat for until things clear. A Pass On Land Based Fish Farms AquaBounty (AQB) is a company developing dry land farms to raise and sell salmon to the market to take demand away from wild caught salmon. The hot words to consider is that these salmon are both genetically engineered and farm raised. Public image issues aside, other risks that have plagued the company are due to the lack of FDA approval (of farm sites) and harvest issues. This has prevented this aging company from seeing any significant development since the early 90s. AquaBounty August Investor Presentation Advantages of the AquaBounty platform, or the trademark AquAdvantage Salmon, are many-fold. Initially, the major benefits revolve around faster growth, reproduction cycles, and ease of harvest, all allowing for a reduction in salmon cost. This either allows AquaBounty to sell at market price for a significant profit, or attempt to steal major market share by offering the lowest prices. Residual effects revolve around the issues inherent in wild-caught fish: ecological impacts, transportation impact, catch risks, food-borne illness, or biomagnification. The current issue is that AquaBounty is still working out the kinks and is yet to produce a full-scale operational facility. However, the bet is that once equilibrium is found, the platform, or these farms and salmon, can be developed worldwide, and the market share looks to be significant. In particular, it seems that commercial usage looks quite favorably upon the genetically engineered salmon, and in time, retail consumers may swing around as well. Investors should feel quite confident in the ability to find customers, but uncertainty around the funding of aquaculture centers and the improvement of harvest yields will be an issue for the coming years. Just look at the small amount of revenues that have been found since initiating the process nearly 30 years ago. Koyfin Revenues are derived from two initial farms in Indiana and Prince Edward Island, Canada. However, these sites will only have a maximum yield of approximately 1,000 metric tons per year. This contrasts significantly with the over 160 million tons of salmon processed per year, in the US. The table below is a great way to realize the sheer size of the fishery market, and to begin understanding the benefits of taking a dent out of the amount of fish we obtain from the oceans. Because of this, AquaBounty’s story will remain not one plagued by demand issues, but rather supply constraints. To combat the lack of supply from their two initial production experiment sites, the company has recently begun construction of a larger 10,000 metric ton facility that will easily provide over 5x current harvest yields. NOAA Fisheries 2020 Report The main problem, as usual, is money. While the company has done well to raise millions at the peak of the recent bull market, current estimates for the price of the new facility will drain the coffer. Now the company is not looking to dilute but to issue bonds instead, partially tempering the hit to current shareholders. However, no funding has come for six quarters and the cash on hand is slowly falling away. As of the August earnings press release, management had the following comments: On the bond financing front, we have decided to slow the process down temporarily in order to evaluate the current economic forces that are driving both inflation and interest rates higher. Since our estimate for construction of the farm currently exceeds our previous range of $290 - $320 million, we will review all options for reducing cost, including potentially phasing the construction of the 10,000 metric ton farm with an initial production output level that would demonstrate our competitive advantage and ability to operate at commercial scale. Koyfin AquaBounty The Future As only uncertainty exists and current supply is only worth a few million per year, I will certainly be remaining on the sideline. However, I look to the success of their construction and will be following their developments. If you are interested in this story, I will offer some valuation points to consider. Based on prices provided by the 2020 NOAA Fisheries report (see above), the value per pound for Salmon is approximately $5/lb at commercial scale.
Seeking Alpha • Aug 09

AquaBounty Technologies GAAP EPS of -$0.08, revenue of $1.07M

AquaBounty Technologies press release (NASDAQ:AQB): Q2 GAAP EPS of -$0.08. Revenue of $1.07M (+365.2% Y/Y).
Seeking Alpha • Mar 15

AquaBounty CEO Sylvia Wulf - Genetically Modified Sustainable Salmon

AquaBounty is an aquaculture company that bioengineered an FDA-approved genetically modified fish (AquAdvantage salmon) that grows faster and requires less food. CEO Sylvia Wulf on challenging GMO misinformation. AquaBounty’s financials and what investors can expect moving forward in terms of capital raises and shareholder dilution.
Analysis Article • May 09

Here's Why AquaBounty Technologies (NASDAQ:AQB) Can Manage Its Debt Despite Losing Money

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Feb 10

What Kind Of Shareholders Hold The Majority In AquaBounty Technologies, Inc.'s (NASDAQ:AQB) Shares?

Every investor in AquaBounty Technologies, Inc. ( NASDAQ:AQB ) should be aware of the most powerful shareholder groups...
Analysis Article • Dec 20

Richard Huber Is The Independent Non-Executive Director of AquaBounty Technologies, Inc. (NASDAQ:AQB) And They Just Picked Up 16% More Shares

Even if it's not a huge purchase, we think it was good to see that Richard Huber, the Independent Non-Executive...

Revenue & Expenses Breakdown

How AquaBounty Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqCM:AQB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 260-430
31 Dec 250-240
30 Sep 2502060
30 Jun 2501960
31 Mar 250-880
31 Dec 240-1190
30 Sep 24-2-31110
30 Jun 24-1-34120
31 Mar 240-10120
31 Dec 230-14131
30 Sep 232-25121
30 Jun 232-25121
31 Mar 233-24121
31 Dec 223-22111
30 Sep 223-22111
30 Jun 223-24112
31 Mar 222-23112
31 Dec 211-22102
30 Sep 211-22102
30 Jun 210-1992
31 Mar 210-1782
31 Dec 200-1672
30 Sep 200-1472
30 Jun 200-1372
31 Mar 200-1482
31 Dec 190-1372
30 Sep 190-1443
30 Jun 190-1453
31 Mar 190-1343
31 Dec 180-1243
30 Sep 180-1174
30 Jun 180-1074
31 Mar 180-1064
31 Dec 170-953
30 Sep 170-963
30 Jun 170-953
31 Mar 170-953
31 Dec 160-853
30 Sep 160-844
30 Jun 160-734
31 Mar 160-744
31 Dec 150-743

Quality Earnings: AQB is currently unprofitable.

Growing Profit Margin: AQB is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: AQB is unprofitable, but has reduced losses over the past 5 years at a rate of 28.5% per year.

Accelerating Growth: Unable to compare AQB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AQB is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (54.5%).

Return on Equity

High ROE: AQB's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 04:39
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AquaBounty Technologies, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Frank BarlowKeefe, Bruyette, & Woods
Benjamin KlieveLake Street Capital Markets, LLC
Colin RuschOppenheimer & Co. Inc.